Abstract
Glioblastoma multiforme (GBM) is the most invasive and undifferentiated type of brain tumour, and so surgical interventions are ineffective. We found that GluR2 is absent in fast-growing GBM-derived tumour stem cells and high-grade glioma specimens, but is expressed in slow-growing stem cells and low-grade glioma specimens. More remarkably, GluR2 overexpression in U-87MG cells inhibits proliferation by inactivating extracellular signal-regulated kinase (ERK)1/2-Src phosphorylation and induces apoptosis. Mechanistically, we observed that the scaffold protein GRIP is essential for the effect of GluR2 on ERK-Src inactivation. These findings indicate that the absence of the GluR2 subunit favours malignancy.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Apoptosis / physiology*
-
Carrier Proteins / metabolism
-
Caspase 3 / metabolism*
-
Caspase 6 / metabolism*
-
Cell Line, Tumor
-
Cell Proliferation
-
Glioma / physiopathology*
-
Humans
-
Intracellular Signaling Peptides and Proteins
-
MAP Kinase Signaling System / physiology*
-
Mitogen-Activated Protein Kinase 1 / metabolism
-
Mitogen-Activated Protein Kinase 3 / metabolism
-
Nerve Tissue Proteins / metabolism
-
Rats
-
Receptors, AMPA / metabolism*
-
src-Family Kinases / metabolism
Substances
-
Carrier Proteins
-
GRIP1 protein, human
-
Grip1 protein, rat
-
Intracellular Signaling Peptides and Proteins
-
Nerve Tissue Proteins
-
Receptors, AMPA
-
src-Family Kinases
-
Mitogen-Activated Protein Kinase 1
-
Mitogen-Activated Protein Kinase 3
-
CASP3 protein, human
-
CASP6 protein, human
-
Casp3 protein, rat
-
Casp6 protein, rat
-
Caspase 3
-
Caspase 6
-
glutamate receptor ionotropic, AMPA 2